Vicki Stone

Quantum dots: an insight and perspective of their biological interaction and how this relates to their relevance for clinical use.

In vitro assessment of engineered nanomaterials using a hepatocyte cell line: cytotoxicity, pro-inflammatory cytokines and functional markers.

An in vitro liver model--assessing oxidative stress and genotoxicity following exposure of hepatocytes to a panel of engineered nanomaterials.

Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications.

Primary human hepatocytes versus hepatic cell line: assessing their suitability for in vitro nanotoxicology.

Effects of silver nanoparticles on the liver and hepatocytes in vitro.

Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges.

An in vitro assessment of panel of engineered nanomaterials using a human renal cell line: cytotoxicity, pro-inflammatory response, oxidative stress and genotoxicity.

The role of Kupffer cells in the hepatic response to silver nanoparticles.

ITS-NANO - Prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy.

Serum enhanced cytokine responses of macrophages to silica and iron oxide particles and nanomaterials: a comparison of serum to lung lining fluid and albumin dispersions.

Hepatic toxicology following single and multiple exposure of engineered nanomaterials utilising a novel primary human 3D liver microtissue model.

Accumulation dynamics and acute toxicity of silver nanoparticles to Daphnia magna and Lumbriculus variegatus: implications for metal modeling approaches.

Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making.

Mechanism of neutrophil activation and toxicity elicited by engineered nanomaterials.

Comparative hazard identification by a single dose lung exposure of zinc oxide and silver nanomaterials in mice.

Multi-walled carbon nanotube induced frustrated phagocytosis, cytotoxicity and pro-inflammatory conditions in macrophages are length dependent and greater than that of asbestos.

Assessing the acute hazards of zinc oxide nanomaterials to Lumbriculus variegatus.

Exploring the cellular and tissue uptake of nanomaterials in a range of biological samples using multimodal nonlinear optical microscopy.

A rapid screening assay for identifying mycobacteria targeted nanoparticle antibiotics.

Impact of serum as a dispersion agent for in vitro and in vivo toxicological assessments of TiO nanoparticles.

A Multilaboratory Toxicological Assessment of a Panel of 10 Engineered Nanomaterials to Human Health--ENPRA Project--The Highlights, Limitations, and Current and Future Challenges.

Expert consensus on an in vitro approach to assess pulmonary fibrogenic potential of aerosolized nanomaterials.

Organ burden and pulmonary toxicity of nano-sized copper (II) oxide particles after short-term inhalation exposure.

Approaches to Develop Alternative Testing Strategies to Inform Human Health Risk Assessment of Nanomaterials.

Neurodegenerative and neurological disorders by small inhaled particles.

Synthesis, characterization and evaluation of in vitro toxicity in hepatocytes of linear polyesters with varied aromatic and aliphatic co-monomers.

Advancing Risk Analysis for Nanoscale Materials: Report from an International Workshop on the Role of Alternative Testing Strategies for Advancement.

A Tractable Method for Measuring Nanomaterial Risk Using Bayesian Networks.

Complete transformation of ZnO and CuO nanoparticles in culture medium and lymphocyte cells during toxicity testing.

Silver Nanoparticles and Metallic Silver Interfere with the Griess Reaction: Reduction of Azo Dye Formation via a Competing Sandmeyer-Like Reaction.

The effect of aluminium and sodium impurities on the in vitro toxicity and pro-inflammatory potential of cristobalite.

Development of an in vitro co-culture model to mimic the human intestine in healthy and diseased state.

Impact of copper oxide nanomaterials on differentiated and undifferentiated Caco-2 intestinal epithelial cells; assessment of cytotoxicity, barrier integrity, cytokine production and nanomaterial penetration.

Nanomaterials Versus Ambient Ultrafine Particles: An Opportunity to Exchange Toxicology Knowledge.

Aligning nanotoxicology with the 3Rs: What is needed to realise the short, medium and long-term opportunities?

Transcriptional profiling reveals gene expression changes associated with inflammation and cell proliferation following short-term inhalation exposure to copper oxide nanoparticles.

Adoption of in vitro systems and zebrafish embryos as alternative models for reducing rodent use in assessments of immunological and oxidative stress responses to nanomaterials.

The Essential Elements of a Risk Governance Framework for Current and Future Nanotechnologies.

Transformations of Nanoenabled Copper Formulations Govern Release, Antifungal Effectiveness, and Sustainability throughout the Wood Protection Lifecycle.

Quantitative human health risk assessment along the lifecycle of nano-scale copper-based wood preservatives.

Assessing the bioactivity of crystalline silica in heated high-temperature insulation wools.

Toxicity of copper oxide and basic copper carbonate nanoparticles after short-term oral exposure in rats.

Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape.

The influence of organic modification on the cytotoxicity of clay particles to keratinocytes, hepatocytes and macrophages; an investigation towards the safe use of polymer-clay nanocomposite packaging.

The importance of inter-individual Kupffer cell variability in the governance of hepatic toxicity in a 3D primary human liver microtissue model.

Using 3D gastrointestinal tract in vitro models with microfold cells and mucus secreting ability to assess the hazard of copper oxide nanomaterials.

The mechanism-based toxicity screening of particles with use in the food and nutrition sector via the ToxTracker reporter system.

The variances in cytokine production profiles from non- or activated THP-1, Kupffer cell and human blood derived primary macrophages following exposure to either alcohol or a panel of engineered nanomaterials.

Assessment of nanomaterial-induced hepatotoxicity using a 3D human primary multi-cellular microtissue exposed repeatedly over 21 days - the suitability of the in vitro system as an in vivo surrogate.

Ongoing inflammation enhances the toxicity of engineered nanomaterials: Application of an in vitro co-culture model of the healthy and inflamed intestine.

Use of EpiAlveolar Lung Model to Predict Fibrotic Potential of Multiwalled Carbon Nanotubes.

Polylactic is a Sustainable, Low Absorption, Low Autofluorescence Alternative to Other Plastics for Microfluidic and Organ-on-Chip Applications.

A review of hepatic nanotoxicology - summation of recent findings and considerations for the next generation of study designs.

A Method to Assess the Relevance of Nanomaterial Dissolution During Reactivity Testing.

Improving Quality in Nanoparticle-Induced Cytotoxicity Testing by a Tiered Inter-Laboratory Comparison Study.

An In Vitro Lung System to Assess the Proinflammatory Hazard of Carbon Nanotube Aerosols.

Risk Management Framework for Nano-Biomaterials Used in Medical Devices and Advanced Therapy Medicinal Products.

Neutrophil activation by nanomaterials : comparing strengths and limitations of primary human cells with those of an immortalized (HL-60) cell line.

Time dependent impact of copper oxide nanomaterials on the expression of genes associated with oxidative stress, metal binding, inflammation and mucus secretion in single and co-culture intestinal in vitro models.

Particulate and drug-induced toxicity assessed in novel quadruple cell human primary hepatic disease models of steatosis and pre-fibrotic NASH.

Grouping Hypotheses and an Integrated Approach to Testing and Assessment of Nanomaterials Following Oral Ingestion.

An Integrated Approach to Testing and Assessment to Support Grouping and Read-Across of Nanomaterials After Inhalation Exposure.

An in vitro assessment of the toxicity of two-dimensional synthetic and natural layered silicates.

Acute hazard assessment of silver nanoparticles following intratracheal instillation, oral and intravenous injection exposures.

Development of a standard operating procedure for the DCFH-DA acellular assessment of reactive oxygen species produced by nanomaterials.

The Road to Achieving the European Commission's Chemicals Strategy for Nanomaterial Sustainability-A PATROLS Perspective on New Approach Methodologies.

An investigation of the hepatic toxicity of PEGylated polymeric redox responsive nanoparticles.

The application of existing genotoxicity methodologies for grouping of nanomaterials: towards an integrated approach to testing and assessment.

Acute waterborne and chronic sediment toxicity of silver and titanium dioxide nanomaterials towards the oligochaete, Lumbriculus variegatus.

How can we justify grouping of nanoforms for hazard assessment? Concepts and tools to quantify similarity.

Bayesian based similarity assessment of nanomaterials to inform grouping.

Pulmonary toxicity and gene expression changes after short-term inhalation exposure to surface-modified copper oxide nanoparticles.

An integrated approach to testing and assessment of high aspect ratio nanomaterials and its application for grouping based on a common mesothelioma hazard.

Determining nanoform similarity via assessment of surface reactivity by abiotic and in vitro assays.

Integrated approaches to testing and assessment for grouping nanomaterials following dermal exposure.

How to formulate hypotheses and IATAs to support grouping and read-across of nanoforms.

Transgenic zebrafish larvae as a non-rodent alternative model to assess pro-inflammatory (neutrophil) responses to nanomaterials.

Grouping MWCNTs based on their similar potential to cause pulmonary hazard after inhalation: a case-study.

Assessing the transferability and reproducibility of 3D in vitro liver models from primary human multi-cellular microtissues to cell-line based HepG2 spheroids.

Comparison of In Vitro Approaches to Assess the Antibacterial Effects of Nanomaterials.

Editorial to the special issue on "similarity assessment of nanoforms: Concepts, tools and case studies of the GRACIOUS project".

Grouping of orally ingested silica nanomaterials via use of an integrated approach to testing and assessment to streamline risk assessment.

Comparative, collaborative, and integrative risk governance for emerging technologies.

Critical aspects in dissolution testing of nanomaterials in the oro-gastrointestinal tract: the relevance of juice composition for hazard identification and grouping.